To confirm that HER2+EVs detected in the plasma of patients by flow cytometry were derived from breast cancer cells, we analysed these EVs for the expression of microRNAs known to be enriched in breast cancer cells [28, 29]. The gene discussed is ERBB2; the disease is breast cancer.